RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: Critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1

Blood

Volumn 111, Issue 6, 2008, Pages 3024-3033

  Garnacho, Carmen ^a   Shuvaev, Vladimir ^a,e   Thomas, Anu ^a   McKenna, Lindsay ^a   Sun, Jing ^b   Koval, Michael ^c   Albelda, Steven ^a,b   Muzykantov, Vladimir ^a,d   Muro, Silvia ^a,d,f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b School of Veterinary Medicine   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Institute for Environmental Medicine   (United States)

^f John Morgan Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALBUMIN; ANTIBODY CONJUGATE; CD31 ANTIGEN; CELL ADHESION MOLECULE; ENHANCED GREEN FLUORESCENT PROTEIN; IODINE 125; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B62; NANOCARRIER; PECAM ANTIBODY; PHALLOIDIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TYROSINE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; ANTIBODY;

ACTIN POLYMERIZATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; C57BL 6 MOUSE; CELL MEMBRANE; CELL TRANSPORT; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; DRUG DELIVERY SYSTEM; DRUG SAFETY; ELECTRON MICROSCOPY; ENDOCYTOSIS; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LUNG CAPILLARY; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRESS FIBER; ANIMAL; C57BL MOUSE; CELL CULTURE; ENZYME ACTIVATION; GENETICS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION;

ACTINS; ANIMALS; ANTIBODIES; ANTIGENS, CD31; CELLS, CULTURED; CYTOPLASM; ENDOCYTOSIS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; RHOA GTP-BINDING PROTEIN; TYROSINE;

EID: 42449138333     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-06-098657     Document Type: Article

References (63)

1. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required fortransendothelial migration of leukocytes. J Exp Med. 1993;178:449-460.
2. Ferrero E, Ferrero ME, Pardi R, Zocchi MR. The platelet endothelial cell adhesion molecule-1 (PECAM1) contributes to endothelial barrier function. FEBS Lett. 1995;374:323-326.
3. Wakelin MW Sanz MJ, Dewar A, et al. An antiplatelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med. 1996;184:229-239.
4. Liao F, Ali J, Greene T, Muller WA. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med. 1997;185:1349-1357.
5. Nakada MT, Amin K, Christofidou-Solomidou M, et al. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PEGAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment. J Immunol. 2000;164:452-462.
6. Muro S, Muzykantov VR, Murciano JC. Characterization of endothelial internalization and targeting of antibody-enzyme conjugates in cell cultures and in laboratory animals. Methods Mol Biol. 2004;283:21-36.
7. Ding BS, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR. Advanced drug delivery systems that target the vascular endothelium. Mol Interv. 2006; 6:98-112.
8. Muller WA, Ratti CM, McDonnell SL, Cohn ZA. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med. 1989:170:399-414.
9. Sun J, Williams J, Yan HC, Amin KM, Albelda SM, DeLisser HM. Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem. 1996;271:18561-18570.
10. Newman PJ, Berndt MC, Gorski J, etal. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 1990;247:1219-1222.
11. Vaporciyan AA, DeLisser HM, Yan HC, et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science. 1993;262:1580-1582.
12. Muzykantov VR, Christofidou-Solomidou M, Balyasnikova I, et al. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci U S A. 1999;96:2379-2384.
13. Ding BS, Gottstein C, Grunow A, et al. Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature. Blood. 2005;106:4191-4198.
14. Wiewrodt R, Thomas AP, Cipelletti L, et al. Sizedependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood. 2002; 99:912-922.
15. Muro S, Wiewrodt R, Thomas A, et al. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci. 2003;116: 1599-1609.
16. Stan RV. Endocytosis pathways in endothelium: how many? Am J Physiol Lung Cell Mol Physiol. 2006;290:L806-L808.
17. Kozower BD, Christofidou-Solomidou M, Sweitzer TD, etal. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol. 2003;21:392-398.
18. Christofidou-Solomidou M, Scherpereel A, Wiewrodt R, et al. PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. Am J Physiol Lung Cell Mol Physiol. 2003;285:L283-L292.
19. Muro S, Mateescu M, Gajewski C, Robinson M. Muzykantov VR, Koval M. Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins. Am J Physiol Lung Cell Mol Physiol. 2006;290:L809-L817.
20. Greenwood J, Walters CE, Pryce G, et al. Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis. FASEB J. 2003;17:905-907.
21. Kaufman DA, Albelda SM, Sun J, Davies PF. Role of lateral cell-cell border location and extracellular/transmembrane domains in PECAM/CD31 mechanosensation. Biochern Biophys Res Gommun. 2004;320:1076-1081.
22. Sun J, Paddock C, Shubert J, et al. Contributions of the extracellular and cytoplasmic domains of platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) in regulating cell-cell localization. J Cell Sci. 2000;113:1459-1469.
23. Lu TT, Yan LG, Madri JA. Integrin engagement mediates tyrosine dephosphorylation on plateletendothelial cell adhesion molecule 1. Proc Natl Acad Sci U S A. 1996;93:11808-11813.
24. Gratzinger D, Canosa S, Engelhardt B, Madri JA. Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. FASEB J. 2003;17:1458-1469.
25. O'Brien CD, Cao G, Makrigiannakis A, DeLisser HM. Role of immunoreceptortyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration. Am J Physiol Cell Physiol. 2004;287:C1103-C1113.
26. Osawa M, Masuda M, Harada N, Lopes RB, Fujiwara K. Tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) in mechanically stimulated vascular endothelial cells. Eur J Cell Biol. 1997;72:229-237.
27. Osawa M, Masuda M, Kusano K. Fujiwara K. Evidence for a role of platelet endothelial cell adhesion molecule-1 in endothelial cell mechanosignal transduction: is it a mechanoresponsive molecule? J Cell Biol. 2002;158:773-785.
28. Man N, Cheung L, Pinter E, Madri JA. Plateletendothelial cell adhesion molecule-1 (CD31). a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem. 2000;275:21435-21443.
29. Biswas P, Canosa S, Schoenfeld D, et al. PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation. Am J Pathol. 2006;169:314-324.
30. Smythe WR, Hwang HC, Amin KM, et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res. 1994;54:2055-2059.
31. DeLisser HM, Chilkotowsky J, Yan HC, Daise ML, Buck GA, Albelda SM. Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties. J Gell Biol. 1994;124: 195-203.
32. O'Brien CD, Lim P, Sun J, Albelda SM. PECAM-1-dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization. Blood. 2003;101:2816-2825.
33. Jackson DE, Kupcho KR, Newman PJ. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (P ECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem. 1997;272:24868-24875.
34. Yan HC, Pilewski JM, Zhang Q, DeLisser HM, Romer L, Albelda SM. Localization of multiple functional domains on human PECAM-1 (CD31) by monoclonal antibody epitope mapping. Gell Adhes Commun. 1995;3:45-66.
35. Muro S, Gajewski C, Koval M, Muzykantov VR. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood. 2005;105:650-658.
36. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629-635.
37. Tzima E. Role of small GTPases in endothelial cytoskeletal dynamics and the shear stress response. Circ Res. 2006;98:176-185.
38. Romer LH, McLean NV, Yan HC, Daise M, Sun J, DeLisser HM. IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol. 1995;154:6582-6592.
39. Newman PJ. The biology of PECAM-1. J Clin Invest. 1997;100(Suppl):S25- S29.
40. Scalia R, Lefer AM. In vivo regulation of PECAM-1 activity during acute endothelial dysfunction in the rat mesenteric microvasculature. J Leukoc Biol. 1998;64:163-169.
41. Muro S, Koval M, Muzykantov V. Endothelial endocytic pathways: gates for vascular drug delivery. Curr Vasc Pharmacol. 2004;2:281-299.
42. Muro S, Cui X, Gajewski C, Murciano JC, Muzykantov VR, Koval M. Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am J Physiol Cell Physiol. 2003;285:C1339-C1347.
43. Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol. 2003;23:953-964.
44. Harada N, Masuda M, Fujiwara K. Fluid flow and osmotic stress induce tyrosine phosphorylation of an endothelial cell 128 kDa surface glycoprotein. Biochern Biophys Res Commun. 1995;214:69-74.
45. Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol. 1999;163:682-688.
46. Flaswinkel H, Reth M. Dual role of the tyrosine activation motif of the Ig-alpha protein during signal transduction via the B cell antigen receptor. EMBO J. 1994;13:83-89.
47. Hall A, Nobes CD. Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos Trans R Soc Lond B Biol Sci. 2000;355:965-970.
48. Wang Y, Sheibani N. PEGAM-1 isoform-specific activation of MAPK/ERKs and small GTPases: implications in inflammation and angiogenesis. J Cell Biochern. 2006;98:451-468.
49. ShikataY, RiosA, Kawkitinarong K, DePaola N, Garcia JG, Birukov KG. Differential effects of shear stress and cyclic stretch on focal adhesion remodeling, site-specific FAK phosphorylation, and small GTPases in human lung endothelial cells. Exp Cell Res. 2005;304:40-49.
50. Kaunas R, Nguyen P, Usami S, Chien S. Cooperative effects of Rho and mechanical stretch on stress fiber organization. Proc Natl Acad Sci U S A. 2005;102:15895-15900.
51. Worthylake RA, Burridge K. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr Opin Cell Biol. 2001; 13:569-577.
52. Luscinskas FW, Ma S, Nusrat A, Parkos CA, Shaw SK. The role of endothelial cell lateral junctions during leukocyte trafficking. Immunol Rev. 2002;186:57-67.
53. Stevens T Garcia JG, Shasby DM, Bhattacharya J, Malik AB. Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol. 2000;279:L419-L422.
54. Ayalon O, Sabanai H, Lampugnani MG, Dejana E, Geiger B. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Gell Biol. 1994;126:247-258.
55. MatsumuraT, Wolff K, Petzelbauer P. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol. 1997;158:3408-3416.
56. Mamdouh Z, Chen X, Pierini LM, Maxfield FR, Muller WA. Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature. 2003;421:748-753.
57. Muzykantov VR. Biomedical aspects of targeted delivery of drugs to pulmonary endothelium. Expert Opin Drug Deliv. 2005;2:909-926.
58. Valadon P, Garnett JD, Testa JE, Bauerle M, Oh P, Schnitzer JE. Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci U S A. 2006:103:407-412.
59. Mahooti S, Graesser D, Patil S, et al. PECAM-1 (CD31) expression modulates bleeding time in vivo. Am J Pathol. 2000;157:75-81.
60. Graesser D, Solowiej A, Bruckner M, et al. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest. 2002;109: 383-392.
61. Maas M, Stapleton M, Bergom C, Mattson DL, Newman DK, Newman PJ. Endothelial cell PECAM-1 confers protection against endotoxic shock. Am J Physiol Heart Circ Physiol. 2005; 288:H159-H164.
62. Carrithers M, Tandon S, Canosa S. Michaud M, Graesser D, Madri J A. Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31 -deficient mice. Am J Pathol. 2005;166:185-196.
63. Perkowski S, Scherpereel A, Murciano JC, et al. Dissociation between alveolar transmigration of neutrophils and lung injury in hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2006;291:L1050-L1058.